Literature DB >> 10760293

IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment.

F H Qiu1, K Wada, G L Stahl, C N Serhan.   

Abstract

We examined gene regulation in murine lungs after hind-limb vessel occlusion and reperfusion. A rapid increase of transcript for the AMP deaminase 3 gene (AMPD3) and its enzymatic activity (EC) generating inosine monophosphate (IMP) were identified with transcripts located in bronchial and alveolar epithelium. AMP deaminase inhibitor decreased IMP levels and significantly enhanced neutrophil recruitment within lung tissue during reperfusion. In addition, IMP inhibited cytokine-initiated neutrophil infiltration in vivo and selectively attenuated neutrophil rolling by 90% in microvessels. We prepared labeled IMP and demonstrated that IMP specifically binds to neutrophils. IMP also stimulated binding of gamma-[(35)S]thio-GTP, suggesting that IMP is a potent regulator of neutrophils. Taken together, these results elucidate a previously unrecognized mechanism that protects tissues from the potentially deleterious consequences of aberrant neutrophil accumulation. Moreover, they are relevant for new therapeutic approaches to regulate neutrophil responses in inflammation and vascular disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760293      PMCID: PMC18224          DOI: 10.1073/pnas.97.8.4267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

Authors:  P Liang; A B Pardee
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  A specific AMP deaminase assay and its application to tissue homogenates.

Authors:  J P Raffin; M T Thebault
Journal:  Comp Biochem Physiol B       Date:  1991

Review 3.  The pathophysiology of aortic cross-clamping and unclamping.

Authors:  S Gelman
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

4.  Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury.

Authors:  A M Lefer; X L Ma; A Weyrich; D J Lefer
Journal:  Agents Actions Suppl       Date:  1993

5.  Purine metabolic pathways in rat hindlimb perfusion model during ischemia and reperfusion.

Authors:  B Soussi; K Lagerwall; J P Idström; T Scherstén
Journal:  Am J Physiol       Date:  1993-10

6.  Tourniquet release: systemic and metabolic effects.

Authors:  H S Townsend; S B Goodman; D J Schurman; A Hackel; J G Brock-Utne
Journal:  Acta Anaesthesiol Scand       Date:  1996-11       Impact factor: 2.105

7.  Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury.

Authors:  A Seekamp; J S Warren; D G Remick; G O Till; P A Ward
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Authors:  B N Cronstein; D Naime; E Ostad
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 9.  Ischemia-reperfusion injury.

Authors:  A Seekamp; P A Ward
Journal:  Agents Actions Suppl       Date:  1993

10.  Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.

Authors:  S Fiore; J F Maddox; H D Perez; C N Serhan
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

2.  Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals.

Authors:  Rong Yang; Gabrielle Fredman; Sriram Krishnamoorthy; Nitin Agrawal; Daniel Irimia; Daniele Piomelli; Charles N Serhan
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

3.  Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.

Authors:  Kie Kasuga; Rong Yang; Timothy F Porter; Nitin Agrawal; Nicos A Petasis; Daniel Irimia; Mehmet Toner; Charles N Serhan
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 4.  Novel anti-inflammatory--pro-resolving mediators and their receptors.

Authors:  Charles N Serhan; Sriram Krishnamoorthy; Antonio Recchiuti; Nan Chiang
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  Highly conserved transcriptional responses to mechanical ventilation of the lung.

Authors:  Kenneth S Kompass; Gaetan Deslee; Carla Moore; Donald McCurnin; Richard A Pierce
Journal:  Physiol Genomics       Date:  2010-05-11       Impact factor: 3.107

6.  The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  Shock       Date:  2009-09       Impact factor: 3.454

7.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

8.  Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.

Authors:  Nazila Kamaly; Gabrielle Fredman; Manikandan Subramanian; Suresh Gadde; Aleksandar Pesic; Louis Cheung; Zahi Adel Fayad; Robert Langer; Ira Tabas; Omid Cameron Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

9.  Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation.

Authors:  Jeremy W Winkler; Stephania Libreros; Xavier De La Rosa; Brian E Sansbury; Paul C Norris; Nan Chiang; David Fichtner; Gregory S Keyes; Nicholas Wourms; Matthew Spite; Charles N Serhan
Journal:  J Leukoc Biol       Date:  2018-01-29       Impact factor: 4.962

10.  Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1.

Authors:  Masakazu Shinohara; Megumi Kibi; Ian R Riley; Nan Chiang; Jesmond Dalli; Bryan D Kraft; Claude A Piantadosi; Augustine M K Choi; Charles N Serhan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-12       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.